12 with a one-stage operative intervention, and three underwent a staged two-phase operative intervention (Fig B) . All patients recovered well, and IVL was confirmed by postoperative pathology. The 15 patients who underwent operation had the pathologic diagnosis of IVL. The specimens were covered by intimal-like tissue, 86.7% (13 of 15) of which was not significant adhere to venous wall, and 53.3% (8 of 15) of which had two and more lesions. Postoperative follow-up (range, 1-14 years; mean, 3.8 years) was performed by both a telephone follow-up call and as in-person outpatient follow-up. One patient who underwent a two-stage case relapsed, and radical surgery was performed again. One patient who deferred operative intervention and died 5 years following diagnosis of unknown cause.
Conclusions: Imaging examinations including B-mode ultrasound imaging, CT, and MRI are highly diagnostic for vena cava tumors such as leiomyomatosis. Surgical tumor removal and debulking via a one-stage or multistaged operative intervention is successful and has reasonable outcomes.
Author Disclosures: H. Fang: Nothing to disclose; B. Jin: Nothing to disclose; Y. Li: Nothing to disclose; P. Lv: Nothing to disclose; C. Yang: Nothing to disclose; Y. Yang: Nothing to disclose; M. A. Zayed: Nothing to disclose; H. Zheng: Nothing to disclose. is becoming a common treatment option for venous insufficiency. Treatment of venous insufficiency has been based on treatment of venous reflux. We examined the effect that iliac vein stenting had on reflux times prestenting and poststenting.
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Effect of Iliac Vein Stenting of NIVLs on Venous Reflux Times
Methods: From September 2012 to August 2016, we performed 1629 venograms with angioplasties and stenting of the iliac veins. These procedures were filtered to only include the venograms where a stent was placed, and no other vascular procedures were performed between "pre" and "post" infrarenal duplex venous mapping tests. This was done to ensure that the iliac vein stent placed was the only procedure affecting the venous reflux. This left a total of 515 procedures that were performed. Reflux was measured using ipsilateral ultrasound imaging.
Results: The average age of the patients were 64.68 years old (range, 24-95; standard deviation, 14.35), with 341 females and 173 males. The CEAP scores were C 2 (0.91%), C 3 (21.14%), C 4 (56.36%), C 5 (5.00%), and C 6 (16.59%). The Table reports the average reflux values, pre-/poststent, and the nonsignificant tendency of decrease in reflux.
Conclusions: There is no statistical significance between infrainguinal reflux times in the reflux time. These data suggest that the previously documented improvement in the patient's symptoms may be due to other mechanisms. Hamamatsu University School of Medicine, Hamamatsu, Japan Objectives: Acute aortic dissection (AAD) is a common disease among the elderly. Although several risk factors of AAD have been reported, the molecular mechanism underlying AAD development remains to be elucidated. Recent findings based on lipid molecular analysis have made a major contribution to the understanding of the pathogenesis of cardiovascular diseases, and it is now recognized that metabolic abnormalities, especially serum dyslipidemia, correlate with AAD onset and aortic rupture. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted enzyme that promotes the degradation of surface low-density lipoprotein (LDL) receptors (LDLRs), preventing the removal of LDL-cholesterol from the blood. Therefore, a PCSK9 inhibitor is a promising therapeutic tool for treating cardiovascular diseases. In this study, the objective was to elucidate the role of PCSK9 in the pathogenesis of AAD.
Methods: We used fluorescence immunohistochemistry to assess PCSK9 expression in the aortic tissues resected from 10 AAD patients and in normal aortic tissues from five autopsy samples as well as in an experimental aortic dissection (AD) model based on spontaneously hyperlipidemic apolipoprotein E-deficient mice.
Results: Histologically, PCSK9 expression in aortic tissue was significantly higher in AAD than that in control patients, and a characteristic distribution pattern of PCSK9 was found in atherosclerotic plaques and the degenerated tunica media in AAD tissues, which was rarely observed in normal aortic tissues. Smooth muscle cells were positively stained for PCSK9, which was confirmed by costaining with the smooth muscle cell marker. Furthermore, PCSK9 expression appeared significantly stronger in comparison with the tissues not accompanied with medial arterial calcification. Finally, we analyzed the level of PCSK9 expression on aneurysm formation via aortic dissection using the mice aorta. The fluorescence intensity of PCSK9 expression in media of aortic dissection mice was elevated by approximately fourfold compared with that of control mice 28 days after the procedure, indicating that the animal model confirmed PCSK9 expression in AD tissues (Fig) .
Conclusions: Our findings suggest that PCSK9 expression in aortic tissues may promote AAD. This study adds to the growing body of evidence supporting the use of PCSK9 inhibitors for the management of AAD. 
